Frizzled receptor 6 marks rare, highly tumourigenic stem-like cells in mouse and human neuroblastomas

Oncotarget

Volumn 2, Issue 12, 2011, Pages 976-983

  Cantilena, Sandra ^a   Pastorino, Fabio ^c   Pezzolo, Annalisa ^c   Chayka, Olesya ^a   Pistoia, Vito ^c   Ponzoni, Mirco ^c   Sala, Arturo ^a,b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b BRUNEL UNIVERSITY   (United Kingdom)

^c G GASLINI INSTITUTE   (Italy)

Author keywords

HIF; Hypoxia; Metastasis; Neuroblastoma; Stem cell

Indexed keywords

BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; DOXORUBICIN; ENDOTHELIAL PAS DOMAIN CONTAINING PROTEIN 1; ENDOTHELIAL PAS DOMAIN-CONTAINING PROTEIN 1; FRIZZLED PROTEIN; FZD6 PROTEIN, HUMAN; HIF1A PROTEIN, HUMAN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; NOTCH1 PROTEIN, HUMAN; NOTCH1 RECEPTOR; NUCLEAR PROTEIN; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR TWIST; TUMOR MARKER; TWIST1 PROTEIN, HUMAN;

ANIMAL; ANOXIA; ARTICLE; CANCER STEM CELL; GENETICS; HUMAN; METABOLISM; MOUSE; NEUROBLASTOMA; PATHOLOGY; PROGNOSIS; RNA INTERFERENCE; TUMOR CELL CULTURE; WNT SIGNALING PATHWAY;

ANIMALS; ANOXIA; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; DOXORUBICIN; FRIZZLED RECEPTORS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MICE; NEOPLASTIC STEM CELLS; NEUROBLASTOMA; NUCLEAR PROTEINS; PROGNOSIS; RECEPTOR, NOTCH1; RNA INTERFERENCE; RNA, SMALL INTERFERING; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL; TWIST TRANSCRIPTION FACTOR; WNT SIGNALING PATHWAY;

EID: 84862994011     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.410     Document Type: Article

References (21)

1. Brodeur GM. Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer. 2003; 3:203-216.
2. Barembaum M, Bronner-Fraser M. Early steps in neural crest specification. Semin Cell Dev Biol. 2005; 16:642-646.
3. Burstyn-Cohen T, Stanleigh J, Sela-Donenfeld D, Kalcheim C. Canonical Wnt activity regulates trunk neural crest delamination linking BMP/noggin signaling with G1/S transition. Development. 2004; 131:5327-5339.
4. Lyuksyutova AI, Lu CC, Milanesio N, King LA, Guo N, Wang Y, Nathans J, Tessier-Lavigne M, Zou Y. Anteriorposterior guidance of commissural axons by Wnt-frizzled signaling. Science. 2003; 302:1984-1988.
5. Reya T, Clevers H. Wnt signalling in stem cells and cancer. Nature. 2005; 434:843-850.
6. Kuriyama S, Mayor R. Molecular analysis of neural crest migration. Philos Trans R Soc Lond B Biol Sci. 2008; 363:1349-1362.
7. Summerhurst K, Stark M, Sharpe J, Davidson D, Murphy P. 3D representation of Wnt and Frizzled gene expression patterns in the mouse embryo at embryonic day 11.5 (Ts19). Gene Expr Patterns. 2008; 8:331-348.
8. Fischer T, Guimera J, Wurst W, Prakash N. Distinct but redundant expression of the Frizzled Wnt receptor genes at signaling centers of the developing mouse brain. Neuroscience. 2007; 147:693-711.
9. Guo N, Hawkins C, Nathans J. Frizzled6 controls hair patterning in mice. Proceedings of the National Academy of Sciences of the United States of America. 2004; 101:9277-9281.
10. Stuebner S, Faus-Kessler T, Fischer T, Wurst W, Prakash N. Fzd3 and Fzd6 deficiency results in a severe midbrain morphogenesis defect. Dev Dyn. 2010; 239:246-260.
11. Wang Y, Guo N, Nathans J. The role of Frizzled3 and Frizzled6 in neural tube closure and in the planar polarity of inner-ear sensory hair cells. J Neurosci. 2006; 26:2147-2156.
12. Wu QL, Zierold C, Ranheim EA. Dysregulation of Frizzled 6 is a critical component of B-cell leukemogenesis in a mouse model of chronic lymphocytic leukemia. Blood. 2009; 113:3031-3039.
13. Heddleston JM, Li Z, Lathia JD, Bao S, Hjelmeland AB, Rich JN. Hypoxia inducible factors in cancer stem cells. Br J Cancer. 2010; 102:789-795.
14. Chayka O, Corvetta D, Dews M, Caccamo AE, Piotrowska I, Santilli G, Gibson S, Sebire NJ, Himoudi N, Hogarty MD, Anderson J, Bettuzzi S, Thomas-Tikhonenko A, Sala A. Clusterin, a haploinsufficient tumor suppressor gene in neuroblastomas. J Natl Cancer Inst. 2009; 101:663-677.
15. Smith KM, Datti A, Fujitani M, Grinshtein N, Zhang L, Morozova O, Blakely KM, Rotenberg SA, Hansford LM, Miller FD, Yeger H, Irwin MS, Moffat J, Marra MA, Baruchel S, Wrana JL et al. Selective targeting of neuroblastoma tumour-initiating cells by compounds identified in stem cell-based small molecule screens. EMBO molecular medicine. 2010; 2:371-384.
16. Heinonen KM, Vanegas JR, Lew D, Krosl J, Perreault C. Wnt4 enhances murine hematopoietic progenitor cell expansion through a planar cell polarity-like pathway. PloS one. 2011; 6:e19279.
17. Pezzolo A, Parodi F, Marimpietri D, Raffaghello L, Cocco C, Pistorio A, Mosconi M, Gambini C, Cilli M, Deaglio S, Malavasi F, Pistoia V. Oct-4+/Tenascin C+ neuroblastoma cells serve as progenitors of tumor-derived endothelial cells. Cell Res. 2011; 21:1470-1486.
18. Wagner W, Ansorge A, Wirkner U, Eckstein V, Schwager C, Blake J, Miesala K, Selig J, Saffrich R, Ansorge W, Ho AD. Molecular evidence for stem cell function of the slowdividing fraction among human hematopoietic progenitor cells by genome-wide analysis. Blood. 2004; 104:675-686.
19. Pietras A, Hansford LM, Johnsson AS, Bridges E, Sjolund J, Gisselsson D, Rehn M, Beckman S, Noguera R, Navarro S, Cammenga J, Fredlund E, Kaplan DR, Pahlman S. HIF-2alpha maintains an undifferentiated state in neural crest-like human neuroblastoma tumor-initiating cells. Proceedings of the National Academy of Sciences of the United States of America. 2009; 106:16805-16810.
20. Hansford LM, McKee AE, Zhang L, George RE, Gerstle JT, Thorner PS, Smith KM, Look AT, Yeger H, Miller FD, Irwin MS, Thiele CJ, Kaplan DR. Neuroblastoma cells isolated from bone marrow metastases contain a naturally enriched tumor-initiating cell. Cancer Res. 2007; 67:11234-11243.
21. Mahller YY, Williams JP, Baird WH, Mitton B, Grossheim J, Saeki Y, Cancelas JA, Ratner N, Cripe TP. Neuroblastoma cell lines contain pluripotent tumor initiating cells that are susceptible to a targeted oncolytic virus. PloS one. 2009; 4:e4235.